285 related articles for article (PubMed ID: 17136887)
1. Importance of the structure of vancomycin binding pocket in designing compounds active against vancomycin-resistant enterococci (VRE).
Jia Y; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
J Antibiot (Tokyo); 2006 Sep; 59(9):543-52. PubMed ID: 17136887
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of simple macrocycles active against vancomycin-resistant enterococci (VRE).
Jia Y; Ma N; Liu Z; Bois-Choussy M; Gonzalez-Zamora E; Malabarba A; Brunati C; Zhu J
Chemistry; 2006 Jul; 12(20):5334-51. PubMed ID: 16634107
[TBL] [Abstract][Full Text] [Related]
3. Identification of synthetic compounds active against VRE: the role of the lipidated aminoglucose and the structure of glycopeptide binding pocket.
Jia Y; Gonzalez-Zamora E; Ma N; Liu Z; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
Bioorg Med Chem Lett; 2005 Oct; 15(20):4594-9. PubMed ID: 16099650
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of macrocycles active against vancomycin-resistant enterococci (VRE): the interplay between d-Ala-d-Lac binding and hydrophobic effect.
Ma N; Jia Y; Liu Z; Gonzalez-Zamora E; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
Bioorg Med Chem Lett; 2005 Feb; 15(3):743-6. PubMed ID: 15664849
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial activity of calozeyloxanthone isolated from Calophyllum species against vancomycin-resistant Enterococci (VRE) and synergism with antibiotics.
Sakagami Y; Kajimura K; Wijesinghe WM; Dharmaratne HR
Planta Med; 2002 Jun; 68(6):541-3. PubMed ID: 12094300
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of vancomycin-resistant enterococci in relation to the administration of glycopeptide antibiotics.
Kolár M; Vágnerová I; Látal T; Kohnová I
Acta Univ Palacki Olomuc Fac Med; 1999; 142():69-71. PubMed ID: 10743728
[TBL] [Abstract][Full Text] [Related]
7. The vancomycin-nisin(1-12) hybrid restores activity against vancomycin resistant Enterococci.
Arnusch CJ; Bonvin AM; Verel AM; Jansen WT; Liskamp RM; de Kruijff B; Pieters RJ; Breukink E
Biochemistry; 2008 Dec; 47(48):12661-3. PubMed ID: 18989934
[TBL] [Abstract][Full Text] [Related]
8. Selective cleavage of D-Ala-D-Lac by small molecules: re-sensitizing resistant bacteria to vancomycin.
Chiosis G; Boneca IG
Science; 2001 Aug; 293(5534):1484-7. PubMed ID: 11520986
[TBL] [Abstract][Full Text] [Related]
9. D-Ala-D-lac binding is not required for the high activity of vancomycin dimers against vancomycin resistant enterococci.
Jain RK; Trias J; Ellman JA
J Am Chem Soc; 2003 Jul; 125(29):8740-1. PubMed ID: 12862465
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin-resistant enterococci in Brooklyn, New York: a moment in time.
Landman D; Volkert F; Manikal V; Saurina G; Ruan Y; Oydna E; Parola C; Quale J
Clin Infect Dis; 1999 Dec; 29(6):1587-8. PubMed ID: 10585828
[No Abstract] [Full Text] [Related]
12. Multivalent antibiotics via metal complexes: potent divalent vancomycins against vancomycin-resistant enterococci.
Xing B; Yu CW; Ho PL; Chow KH; Cheung T; Gu H; Cai Z; Xu B
J Med Chem; 2003 Nov; 46(23):4904-9. PubMed ID: 14584941
[TBL] [Abstract][Full Text] [Related]
13. A new chromogenic agar medium, chromID VRE, to screen for vancomycin-resistant Enterococcus faecium and Enterococcus faecalis.
Ledeboer NA; Tibbetts RJ; Dunne WM
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):477-9. PubMed ID: 17889490
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of 16-membered cyclopeptides active against vancomycin-resistant Enterococci (VRE).
Zhu J
Chimia (Aarau); 2013; 67(12-13):916-20. PubMed ID: 24594338
[TBL] [Abstract][Full Text] [Related]
15. Emerging vancomycin resistance in enterococci in India.
Ghoshal U; Garg A; Tiwari DP; Ayyagari A
Indian J Pathol Microbiol; 2006 Oct; 49(4):620-2. PubMed ID: 17183879
[TBL] [Abstract][Full Text] [Related]
16. In vitro analysis of resistance selection by linezolid in vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium.
Allen GP; Bierman BC
Int J Antimicrob Agents; 2009 Jul; 34(1):21-4. PubMed ID: 19243921
[TBL] [Abstract][Full Text] [Related]
17. [Molecular characterization of vancomycin-resistant enterococci isolates].
Liu YM; Cao B; Wang H; Li BB; Yang CX; Wang QT; Du XL; Li F; Wang SS; Qu SS
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(11):760-3. PubMed ID: 18683685
[TBL] [Abstract][Full Text] [Related]
18. [A 6-year study of glycopeptides-resistant enterococci in 3 intensive care units of the University Hospital of Montpellier].
Godreuil S; Marchandin H; Boulier A; Boumzebra A; Campos J; Jean-Pierre H
Pathol Biol (Paris); 2007 Nov; 55(8-9):418-23. PubMed ID: 17905540
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program.
Deshpande LM; Fritsche TR; Moet GJ; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2007 Jun; 58(2):163-70. PubMed ID: 17368801
[TBL] [Abstract][Full Text] [Related]
20. Effect of banning vancomycin analogue avoparcin on vancomycin-resistant enterococci in chicken farms in Taiwan.
Lauderdale TL; Shiau YR; Wang HY; Lai JF; Huang IW; Chen PC; Chen HY; Lai SS; Liu YF; Ho M
Environ Microbiol; 2007 Mar; 9(3):819-23. PubMed ID: 17298380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
